Announced
Completed
Synopsis
Varian, an American radiation oncology treatments and software maker, completed the acquisition of Endocare and Alicon, two cancer care solutions providers, for $185m. These acquisitions provide Varian with a leading position in the high-value interventional oncology segment, which is expected to grow from approximately $860m in 2019 to over $1bn in 2022.
Principals
Show Details & Financials
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.